NasdaqGS:ISRG

Stock Analysis Report

Executive Summary

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories.

Snowflake

Fundamentals

Flawless balance sheet with proven track record.


Similar Companies

Share Price & News

How has Intuitive Surgical's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

3.8%

ISRG

-0.003%

US Medical Equipment

1.3%

US Market


1 Year Return

-2.7%

ISRG

11.9%

US Medical Equipment

5.9%

US Market

Return vs Industry: ISRG underperformed the US Medical Equipment industry which returned 11.9% over the past year.

Return vs Market: ISRG underperformed the US Market which returned 5.9% over the past year.


Shareholder returns

ISRGIndustryMarket
7 Day3.8%-0.003%1.3%
30 Day1.0%-3.0%-1.9%
90 Day0.9%-0.6%-1.8%
1 Year-2.7%-2.7%12.8%11.9%8.3%5.9%
3 Year119.6%119.6%69.6%64.5%45.6%36.2%
5 Year219.6%219.6%129.6%104.0%66.1%47.9%

Price Volatility Vs. Market

How volatile is Intuitive Surgical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Intuitive Surgical undervalued compared to its fair value and its price relative to the market?

50.08x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Undervalued: ISRG ($528.21) is trading above our estimate of fair value ($457.31)

Significantly Undervalued: ISRG is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: ISRG is poor value based on its PE Ratio (50.1x) compared to the Medical Equipment industry average (40.1x).

PE vs Market: ISRG is poor value based on its PE Ratio (50.1x) compared to the US market (17.5x).


Price to Earnings Growth Ratio

Low PEG Ratio: ISRG is poor value based on its PEG Ratio (5.7x)


Price to Book Ratio

PB vs Industry: ISRG is overvalued based on its PB Ratio (8.4x) compared to the US Medical Equipment industry average (3.6x).


Next Steps

Future Growth

How is Intuitive Surgical forecast to perform in the next 1 to 3 years based on estimates from 18 analysts?

8.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ISRG's forecast earnings growth (8.8% per year) is above the savings rate (2.7%).

Earnings vs Market: ISRG's earnings (8.8% per year) are forecast to grow slower than the US market (14.4% per year).

High Growth Earnings: ISRG's earnings are forecast to grow, but not significantly.

Revenue vs Market: ISRG's revenue (13.1% per year) is forecast to grow faster than the US market (7.3% per year).

High Growth Revenue: ISRG's revenue (13.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: ISRG's Return on Equity is forecast to be low in 3 years time (19.6%).


Next Steps

Past Performance

How has Intuitive Surgical performed over the past 5 years?

18.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: ISRG's earnings have grown by 18.7% per year over the past 5 years.

Accelerating Growth: ISRG's earnings growth over the past year (49.4%) exceeds its 5-year average (18.7% per year).

Earnings vs Industry: ISRG earnings growth over the past year (49.4%) exceeded the Medical Equipment industry 28.2%.


Return on Equity

High ROE: ISRG's Return on Equity (16.5%) is considered low.


Return on Assets

ROA vs Industry: ISRG has a higher Return on Assets than the Medical Equipment industry average last year.


Return on Capital Employed

ROCE Improving: ISRG has not improved its Return on Capital Employed over the past 3 years.


Next Steps

Financial Health

How is Intuitive Surgical's financial position?


Financial Position Analysis

Short Term Liabilities: ISRG's short term assets ($4.1B) exceeds its short term liabilities ($807.5M)

Long Term Liabilities: ISRG's short term assets (4.1B) exceeds its long term liabilities (444.5M)


Debt to Equity History and Analysis

Debt Level: ISRG is debt free.

Reducing Debt: ISRG has not had any debt for past 5 years.

Debt Coverage: ISRG has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: ISRG has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: ISRG has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if ISRG's debt is covered by short term assets.


Next Steps

Dividend

What is Intuitive Surgical's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage1.2%forecastin3Years0%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate ISRG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate ISRG's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if ISRG's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ISRG's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ISRG's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Intuitive Surgical's salary, the management and board of directors tenure and is there insider trading?

5.9yrs

Average management tenure


CEO

Gary Guthart (53yo)

9.8yrs

Tenure

US$6,423,078

Compensation

Dr. Gary S. Guthart, Ph.D., has been Chief Executive Officer of Intuitive Surgical, Inc. since January 01, 2010 and also had been its President since July 12, 2007 until 2019. Dr. Guthart served as the Chi ...


CEO Compensation Analysis

Compensation vs. Market: Gary's total compensation ($USD6.42M) is below average for companies of similar size in the US market ($USD11.20M).

Compensation vs Earnings: Gary's compensation has increased by more than 20% in the past year.


Management Age and Tenure

5.9yrs

Average Tenure

55yo

Average Age

Experienced Management: ISRG's management team is seasoned and experienced (5.9 years average tenure).


Board Age and Tenure

6.6yrs

Average Tenure

61yo

Average Age

Experienced Board: ISRG's board of directors are considered experienced (6.6 years average tenure).


Insider Trading

Insider Buying: ISRG insiders have only sold shares in the past 3 months.


Recent Insider Transactions

SellUS$106,03420 Aug 19
Lonnie Smith
EntityIndividual
Role
Chairman of the Board
Independent Chairman
Shares215
Max PriceUS$493.18
SellUS$112,00018 May 19
Lonnie Smith
EntityIndividual
Role
Chairman of the Board
Independent Chairman
Shares227
Max PriceUS$493.39
SellUS$114,77728 Feb 19
Lonnie Smith
EntityIndividual
Role
Chairman of the Board
Independent Chairman
Shares210
Max PriceUS$546.56
SellUS$121,50908 Nov 18
Lonnie Smith
EntityIndividual
Role
Chairman of the Board
Independent Chairman
Shares225
Max PriceUS$540.04

Ownership Breakdown


Management Team

  • Marshall Mohr (63yo)

    Executive VP & CFO

    • Tenure: 0yrs
    • Compensation: US$3.33m
  • Gary Guthart (53yo)

    CEO & Director

    • Tenure: 9.8yrs
    • Compensation: US$6.42m
  • Jamie Samath (48yo)

    VP, Corporate Controller & Principal Accounting Officer

    • Tenure: 6yrs
  • Kara Reiter (55yo)

    Senior VP

    • Tenure: 1.3yrs
  • David Stoffel

    Vice President of Marketing & New Business Development

    • Tenure: 5.8yrs
  • Jeroen M. van Heesewijk

    Senior Vice President of International Commercial Strategy

    • Tenure: 4.8yrs
  • Sal Brogna (64yo)

    Executive VP & COO

    • Tenure: 1.9yrs
    • Compensation: US$4.58m
  • Dave Rosa (51yo)

    Executive VP & Chief Business Officer

    • Tenure: 6.8yrs
    • Compensation: US$4.54m
  • Myriam J. McAdams (62yo)

    Executive VP & Chief Medical Officer

    • Tenure: 13.8yrs
    • Compensation: US$4.15m
  • Calvin Darling

    Senior Director of IR

    • Tenure: 0yrs

Board Members

  • Amal Johnson (66yo)

    Independent Director

    • Tenure: 9.5yrs
    • Compensation: US$364.57k
  • Lonnie Smith (75yo)

    Independent Chairman

    • Tenure: 16.5yrs
    • Compensation: US$445.97k
  • Don Kania (64yo)

    Director

    • Tenure: 1.3yrs
    • Compensation: US$236.36k
  • Craig Barratt (57yo)

    Independent lead Director

    • Tenure: 1.5yrs
    • Compensation: US$399.27k
  • Alan Levy (81yo)

    Independent Director

    • Tenure: 19.7yrs
    • Compensation: US$363.57k
  • Jami K. Nachtsheim (60yo)

    Independent Director

    • Tenure: 2.5yrs
    • Compensation: US$350.57k
  • Gary Guthart (53yo)

    CEO & Director

    • Tenure: 9.8yrs
    • Compensation: US$6.42m
  • Keith Leonard (57yo)

    Independent Director

    • Tenure: 3.8yrs
    • Compensation: US$354.57k
  • Amy Ladd

    Director

    • Tenure: 0.2yrs
  • Mark Rubash (61yo)

    Independent Director

    • Tenure: 12yrs
    • Compensation: US$367.57k

Company Information

Intuitive Surgical, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Intuitive Surgical, Inc.
  • Ticker: ISRG
  • Exchange: NasdaqGS
  • Founded: 1995
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$60.878b
  • Shares outstanding: 115.25m
  • Website: https://www.intuitive.com

Number of Employees


Location

  • Intuitive Surgical, Inc.
  • 1020 Kifer Road
  • Sunnyvale
  • California
  • 94086
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ISRGNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDJun 2000
IUI1DB (Deutsche Boerse AG)YesCommon StockDEEURJun 2000
0R29LSE (London Stock Exchange)YesCommon StockGBUSDJun 2000
ISRGWBAG (Wiener Boerse AG)YesCommon StockATEURJun 2000
ISRG *BMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNJun 2000

Biography

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon’s natural hand movements  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/15 23:38
End of Day Share Price2019/10/15 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.